← Leaderboards
Abhijit Patel
Yale University
$5,506,607
Attributed
$7,691,933
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,253,910 · 5
By mechanism
U01$3,390,181 · 1
U2C$2,561,977 · 1
R44$1,999,999 · 1
R01$1,903,713 · 1
R43$398,040 · 1
Top collaborators
- Steven J Skates4 shared
- Michael T Barrett3 shared
- David Yu Zhang2 shared
Most similar at Yale University
Same institution · by research overlap
- James Lorenzen Boyer$31,049,164
- Paul Wesley Noble$36,197,130
- John Lucian Davis$13,237,964
- Prabir Ray$20,599,877
- Naftali Kaminski$42,947,928
Others in their field
Top investigators on “Performance”
- Jeffrey P Krischer · University Of South Florida$413,069,911
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$378,749,497
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$319,618,139
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
Research focus
PerformanceBloodMutationDetectionMalignant NeoplasmsTumor DnaMutantSpecificityCancer BiomarkersBlood TestsSomatic MutationBiological MarkersMalignant Neoplasm Of LungTumorCancer TypeSuccessSamplingBlood CirculationSensitivity And SpecificityBaseTumor-DerivedMorphologic ArtifactsNext Generation SequencingX-Ray Computed Tomography
Grant awards (16)
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA$1,009,228
R44 · FY2025 · CA
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer$952,713
U2C · FY2025 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA$990,771
R44 · FY2024 · CA
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer$922,892
U2C · FY2023 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA$398,040
R43 · FY2023 · CA
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood$947,748
U01 · FY2022 · CA · contact PI
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer$686,372
U2C · FY2022 · CA
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood$967,088
U01 · FY2021 · CA · contact PI
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood$450,480
U01 · FY2020 · CA · contact PI
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer$383,156
R01 · FY2020 · CA · contact PI
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood$504,629
U01 · FY2019 · CA · contact PI
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer$371,660
R01 · FY2019 · CA · contact PI
Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood$520,236
U01 · FY2018 · CA · contact PI
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer$383,156
R01 · FY2018 · CA · contact PI
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer$383,156
R01 · FY2017 · CA · contact PI
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer$382,585
R01 · FY2016 · CA · contact PI